Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    yesterday
    Change Detected
    Summary
    The page footer was updated to reflect a new site revision number, moving from v3.5.2 to v3.5.3. This represents an update to the ClinicalTrials.gov page software version rather than any change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:40:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor version bump with no changes to study content or interactions.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:03.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:06:06.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:20.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:29.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown on the page, replacing the previous v3.4.0. This is a minor site update and does not modify any study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:04.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.